SCHEMBL19646366

SCHEMBL19646366

CC(C)c1cc(C(=O)NCSc2cc(C(=O)O)n[nH]2)n[nH]1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCAR2 Q8TDS4 5/20 0.64
HCAR3 P49019 2/20 0.64
MME P08473 1/20 0.43
NPC1 O15118 4/20 0.43
RAB9A P51151 4/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
MAPT P10636 2/20 0.43
PKM P14618 1/20 0.43
HPGD P15428 1/20 0.43
LMNA P02545 2/20 0.42
PRKAB2 O43741 1/20 0.42
PRKAG1 P54619 1/20 0.42
PRKAA2 P54646 1/20 0.42
PRKAA1 Q13131 1/20 0.42
PRKAG3 Q9UGI9 1/20 0.42
PRKAG2 Q9UGJ0 1/20 0.42
PRKAB1 Q9Y478 1/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
KDM5B Q9UGL1 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1739326 0.80 HCAR2 (1.00) HCAR2HCAR3NPC1RAB9AMAPT
Hydrochloric Acid SCHEMBL31467457 0.79 HCAR2 (0.96) HCAR2HCAR3NPC1RAB9AMAPT
SCHEMBL21401472 0.78 HCAR3 (0.60) HCAR2HCAR3MMENPC1RAB9A
SCHEMBL19646367 0.73 HCAR3 (0.66) HCAR2HCAR3MMENPC1RAB9A
SCHEMBL21401431 0.71 HCAR3 (0.64) HCAR2HCAR3MMENPC1RAB9A
SCHEMBL5599627 0.69 HCAR2 (0.76) HCAR2HCAR3MMEKDM5ADAO
SCHEMBL26784594 0.69 HCAR3 (0.59) HCAR2HCAR3MMENPC1RAB9A
SCHEMBL15253861 0.69 HCAR3 (0.75) HCAR2HCAR3NPC1RAB9ASMN1; SMN2
SCHEMBL5599520 0.68 HCAR2 (0.69) HCAR2HCAR3DAO
SCHEMBL5599868 0.68 HCAR2 (0.69) HCAR2HCAR3DAO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9828370-B2 Compositions and methods for inhibiting kinases INHIBIKASE THERAPEUTICS, INC. (US) 2017-11-28 US disclosed